bioMerieux SA (bioMerieux), a subsidiary of Institut Merieux SA, develops, manufactures, and markets in vitro diagnostic solutions for hospital and private laboratories. The company offers diagnostic solutions such as systems, reagents and software for the diagnosis of infectious diseases, cardiovascular diseases and cancers, besides identifying microorganisms in pharmaceuticals, cosmetics, and agri-food products. It offers immunoassays, microbiology products, molecular biology tests, and other solutions for clinical applications and industrial microbiological control solutions for the food, biopharmaceutical, and cosmetic industries; veterinary diagnostic laboratories; and blood banks. bioMerieux also provides solutions for the enumeration of bacterial flora, which indicate the quality of food products. The company distributes its products directly and through a network of distributors across the world. bioMerieux is headquartered in Marcy l’Etoile, France.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company bioMerieux SA
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- bioMerieux SA Company Overview
- bioMerieux SA Company Snapshot
- bioMerieux SA Pipeline Products and Ongoing Clinical Trials Overview
- bioMerieux SA - Pipeline Analysis Overview
- Business Description
- bioMerieux SA - Key Facts
- bioMerieux SA - Major Products and Services
- bioMerieux SA Pipeline Products by Development Stage
- bioMerieux SA Ongoing Clinical Trials by Trial Status
- bioMerieux SA Pipeline Products Overview
- Annexin A3 Prostate Cancer Marker
- Annexin A3 Prostate Cancer Marker Product Overview
- Argene Sars-Cov-2 R-Gene Test
- Argene Sars-Cov-2 R-Gene Test Product Overview
- BIOFIRE R/ST PANEL
- BIOFIRE R/ST PANEL Product Overview
- Biomarker Test - Chronic Q Fever
- Biomarker Test - Chronic Q Fever Product Overview
- BRAF - Breast Cancer Diagnostic Kit
- BRAF - Breast Cancer Diagnostic Kit Product Overview
- Clinical Digital Solution
- Clinical Digital Solution Product Overview
- Companion Diagnostic Test - Hormone-Dependent Breast Cancer
- Companion Diagnostic Test - Hormone-Dependent Breast Cancer Product Overview
- Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor
- Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor Product Overview
- Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor
- Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor Product Overview
- Companion Diagnostic Test - Hormone-Dependent Prostate Cancer
- Companion Diagnostic Test - Hormone-Dependent Prostate Cancer Product Overview
- Diagnostic Assay - Alcoholism
- Diagnostic Assay - Alcoholism Product Overview
- Diagnostic Assay - Alzheimer's Disease
- Diagnostic Assay - Alzheimer's Disease Product Overview
- Diagnostic Assay - Amyotrophic Lateral Sclerosis
- Diagnostic Assay - Amyotrophic Lateral Sclerosis Product Overview
- Diagnostic Assay - Depression
- Diagnostic Assay - Depression Product Overview
- Diagnostic Assay - Huntington’s Disease
- Diagnostic Assay - Huntington’s Disease Product Overview
- Diagnostic Assay - Hypoxic Ischemic Encephalopathy
- Diagnostic Assay - Hypoxic Ischemic Encephalopathy Product Overview
- Diagnostic Assay - Neuro ICU Monitoring
- Diagnostic Assay - Neuro ICU Monitoring Product Overview
- Diagnostic Assay - Parkinson's Disease
- Diagnostic Assay - Parkinson's Disease Product Overview
- Diagnostic Assay - Prostate Cancer
- Diagnostic Assay - Prostate Cancer Product Overview
- Diagnostic Assay - Seizure
- Diagnostic Assay - Seizure Product Overview
- Diagnostic Assay - Stroke
- Diagnostic Assay - Stroke Product Overview
- Diagnostic Test - Abdominal Pain
- Diagnostic Test - Abdominal Pain Product Overview
- Diagnostic Test - Acute Coronary Syndrome
- Diagnostic Test - Acute Coronary Syndrome Product Overview
- Diagnostic Test - Acute Respiratory Infection
- Diagnostic Test - Acute Respiratory Infection Product Overview
- Diagnostic Test - Cerebrovascular Injury
- Diagnostic Test - Cerebrovascular Injury Product Overview
- Diagnostic Test - Sepsis
- Diagnostic Test - Sepsis Product Overview
- Diagnostic Test - Shaken Baby Syndrome (SBS)
- Diagnostic Test - Shaken Baby Syndrome (SBS) Product Overview
- Diagnostic Test - Tuberculosis
- Diagnostic Test - Tuberculosis Product Overview
- FilmArray 2.0 - Lower Respiratory Tract Panel
- FilmArray 2.0 - Lower Respiratory Tract Panel Product Overview
- FilmArray Febrile Infant Panel
- FilmArray Febrile Infant Panel Product Overview
- FilmArray Pneumonia Panel
- Product Status
- FilmArray Sepsis Direct Panel
- FilmArray Sepsis Direct Panel Product Overview
- FilmArray Sepsis Direct Panel Clinical Trial
- FilmArray STD Panel
- FilmArray STD Panel Product Overview
- Hylia
- Hylia Product Overview
- iMAG
- iMAG Product Overview
- Nephroclear CCL14 Test
- Nephroclear CCL14 Test Product Overview
- Nephroclear CCL14 Test Clinical Trial
- NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test
- NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test Product Overview
- NucliSENS EasyQ Legionella spp Molecular Test
- NucliSENS EasyQ Legionella spp Molecular Test Product Overview
- NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test
- NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test Product Overview
- Spec80
- Spec80 Product Overview
- SpecID System
- SpecID System Product Overview
- Totem
- Totem Product Overview
- Vidas - Nephrocheck
- Vidas - Nephrocheck Product Overview
- VIDAS CXCL9 CDx
- VIDAS CXCL9 CDx Product Overview
- Vidas hsCRP Assay
- Vidas hsCRP Assay Product Overview
- VIDAS TB-IGRA
- VIDAS TB-IGRA Product Overview
- VIDAS TBI
- VIDAS TBI Product Overview
- VITEK REVEAL
- VITEK REVEAL Product Overview
- VITEK REVEAL Clinical Trial
- bioMerieux SA - Key Competitors
- bioMerieux SA - Key Employees
- bioMerieux SA - Key Employee Biographies
- bioMerieux SA - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- bioMerieux SA, Recent Developments
- May 16, 2023: BioMerieux Triples footprint in Philadelphia with 32,000 sq. ft. state-of-the-art predictive diagnostics innovation center
- Apr 14, 2023: Oxford Nanopore and BioMerieux to enter into a strategic partnership agreement to develop innovative infectious disease diagnostics
- Apr 05, 2023: bioMérieux launches BIOFIRE FIREWORKS a cutting-edge, data-driven software solution that takes BIOFIRE Systems to the next level
- Mar 08, 2023: bioMerieux Announces 2022 Financial Results for the year ending December 31, 2022
- Mar 05, 2023: bioMerieux launches BIOFIRE FIREWORKS a cutting-edge, data-driven software solution that takes BIOFIRE systems to the next level
- Sep 21, 2022: BrightInsight and bioMérieux Announce Partnership to Launch Clinical Digital Solutions for Diagnostics
- Jan 06, 2022: French multidisciplinary consortium ARPEGE awarded public funding of close to €9 million to fight antibiotic resistance
- Dec 01, 2021: bioMerieux molecular tests efficiently detect SARS-CoV-2 Omicron variant
- Oct 25, 2021: GC Labs introduces the microbiology Total Laboratory Automation system for the first time in Korea
- Sep 01, 2021: BioMerieux announce First-Half 2021 Results
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- bioMerieux SA Pipeline Products and Ongoing Clinical Trials Overview
- bioMerieux SA Pipeline Products by Equipment Type
- bioMerieux SA Pipeline Products by Indication
- bioMerieux SA Ongoing Clinical Trials by Trial Status
- bioMerieux SA, Key Facts
- bioMerieux SA, Major Products and Services
- bioMerieux SA Number of Pipeline Products by Development Stage
- bioMerieux SA Pipeline Products Summary by Development Stage
- bioMerieux SA Ongoing Clinical Trials by Trial Status
- bioMerieux SA Ongoing Clinical Trials Summary
- Annexin A3 Prostate Cancer Marker - Product Status
- Annexin A3 Prostate Cancer Marker - Product Description
- Argene Sars-Cov-2 R-Gene Test - Product Status
- Argene Sars-Cov-2 R-Gene Test - Product Description
- BIOFIRE R/ST PANEL - Product Status
- BIOFIRE R/ST PANEL - Product Description
- Biomarker Test - Chronic Q Fever - Product Status
- Biomarker Test - Chronic Q Fever - Product Description
- BRAF - Breast Cancer Diagnostic Kit - Product Status
- BRAF - Breast Cancer Diagnostic Kit - Product Description
- Clinical Digital Solution - Product Status
- Clinical Digital Solution - Product Description
- Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Status
- Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Description
- Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor - Product Status
- Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor - Product Description
- Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor - Product Status
- Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor - Product Description
- Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Status
- Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Description
- Diagnostic Assay - Alcoholism - Product Status
- Diagnostic Assay - Alcoholism - Product Description
- Diagnostic Assay - Alzheimer's Disease - Product Status
- Diagnost
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Becton Dickinson and Co
- Eurofins Scientific SE
- Danaher Corp
- Bio-Rad Laboratories Inc
- Sysmex Corp
- Thermo Fisher Scientific Inc
- F. Hoffmann-La Roche Ltd
- OpGen Inc
- Ortho Clinical Diagnostics Holdings Plc
- Siemens Healthineers AG
- Abbott Laboratories
